These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25304538)

  • 21. Reply to: "The serotonin theory of depression: a systematic umbrella review of the evidence" published by Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA in Molecular Psychiatry (2022 Jul 20. doi: 10.1038/s41380-022-01661-0).
    Bartova L; Lanzenberger R; Rujescu D; Kasper S
    Mol Psychiatry; 2023 Aug; 28(8):3153-3154. PubMed ID: 37322062
    [No Abstract]   [Full Text] [Related]  

  • 22. The serotonin theory of depression.
    El-Mallakh RS; Doroodgar M; Elsayed OH; Kidambi N
    Mol Psychiatry; 2023 Aug; 28(8):3157. PubMed ID: 37322061
    [No Abstract]   [Full Text] [Related]  

  • 23. Why are new antidepressants failing to make the grade for approval?
    Möller HJ
    Expert Opin Pharmacother; 2017 May; 18(7):641-643. PubMed ID: 28346023
    [No Abstract]   [Full Text] [Related]  

  • 24. [Wrong etymology].
    Larsen BE
    Tidsskr Nor Laegeforen; 2013 Aug; 133(15):1555. PubMed ID: 23970253
    [No Abstract]   [Full Text] [Related]  

  • 25. Restoring Balance to the Recently Disputed Chemical Imbalance Theory of Depression.
    O'Brien M; Lynch D; Hallahan B; McNicholas F
    Ir Med J; 2022 Oct; 115(No.9):668. PubMed ID: 36920325
    [No Abstract]   [Full Text] [Related]  

  • 26. The Placebo Effect: A Conversation With Dr Irving Kirsch.
    Scott W
    Glob Adv Health Med; 2012 Nov; 1(5):10-1. PubMed ID: 27257521
    [No Abstract]   [Full Text] [Related]  

  • 27. CENTRAL SEROTONIN DEFICIENCY-A FACTOR WHICH INCREASES DEPRESSION VULNERABILITY?
    van Praag HM; de Haan S
    Acta Psychiatr Scand; 1980 Mar; 61(S280):89-96. PubMed ID: 28678369
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serotonin. Medicine. science abroad].
    LEVYOVA J
    Cas Lek Cesk; 1957 Dec; 96(50):193-9. PubMed ID: 13500385
    [No Abstract]   [Full Text] [Related]  

  • 29. Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences.
    Moncrieff J; Kirsch I
    Contemp Clin Trials; 2015 Jul; 43():60-2. PubMed ID: 25979317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed-methods quantitative-qualitative study of 29 nonagenarians and centenarians in rural Southern Italy: focus on positive psychological traits.
    Scelzo A; Di Somma S; Antonini P; Montross LP; Schork N; Brenner D; Jeste DV
    Int Psychogeriatr; 2018 Jan; 30(1):31-38. PubMed ID: 29229012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is longevity a value for older adults?
    Ekerdt DJ; Koss CS; Li A; Münch A; Lessenich S; Fung HH
    J Aging Stud; 2017 Dec; 43():46-52. PubMed ID: 29173514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placebo Effect in the Treatment of Depression and Anxiety.
    Kirsch I
    Front Psychiatry; 2019; 10():407. PubMed ID: 31249537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressants versus placebo for panic disorder in adults.
    Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expert recommendations for Germany's integration of psychedelic-assisted therapy.
    Perez Rosal SR; La Torre JT; Birnkammer S; Chernoloz O; Williams MT; Faber SC
    BMC Med Educ; 2024 Oct; 24(1):1202. PubMed ID: 39443907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placebo stimulates neuroplasticity in depression: implications for clinical practice and research.
    Seymour J; Mathers N
    Front Psychiatry; 2023; 14():1301143. PubMed ID: 38268561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosing.
    Szigeti B; Nutt D; Carhart-Harris R; Erritzoe D
    Sci Rep; 2023 Jul; 13(1):12107. PubMed ID: 37495637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of spiritual healing on moderate depression in adults: a study protocol of a pilot randomised controlled trial (RCT).
    Stub T; Irgens AC; Hansen AH; Knudsen-Baas O; Gåskjenn C; Kristoffersen AE
    BMJ Open; 2022 Sep; 12(9):e062683. PubMed ID: 36109024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial.
    Hjorth OR; Frick A; Gingnell M; Hoppe JM; Faria V; Hultberg S; Alaie I; Månsson KNT; Rosén J; Reis M; Wahlstedt K; Jonasson M; Lubberink M; Antoni G; Fredrikson M; Furmark T
    Transl Psychiatry; 2021 Nov; 11(1):559. PubMed ID: 34732695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putting the 'Art' Into the 'Art of Medicine': The Under-Explored Role of Artifacts in Placebo Studies.
    Bernstein MH; Locher C; Kube T; Buergler S; Stewart-Ferrer S; Blease C
    Front Psychol; 2020; 11():1354. PubMed ID: 32774310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression Studies.
    Whitlock ME; Woodward PW; Alexander RC
    Innov Clin Neurosci; 2019; 16(7-08):12-17. PubMed ID: 31832258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.